VERO
Venus Concept Inc
NASDAQ: VERO · HEALTHCARE · MEDICAL DEVICES
$0.31
+0.00% today
Updated 2026-04-30
Market cap
$578190.00
P/E ratio
—
P/S ratio
0.01x
EPS (TTM)
$-45.26
Dividend yield
—
52W range
$0 – $8
Volume
0.0M
Venus Concept Inc (VERO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-92.80%
Operating margin
-68.90%
ROE
-795.00%
ROA
-32.40%
Debt/equity
12.22x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $17.23M | $-22.97M | 27.38% | -119.12% | -133.32% |
| 2016 | $15.60M | $-21.85M | 33.13% | -121.36% | -140.04% |
| 2017 | $21.30M | $-17.84M | 42.95% | -81.15% | -83.78% |
| 2018 | $21.96M | $-28.73M | 43.30% | -117.99% | -130.83% |
| 2019 | $110.41M | $-42.30M | 69.43% | -18.37% | -38.31% |
| 2020 | $78.01M | $-82.82M | 65.87% | -51.85% | -106.16% |
| 2021 | $105.62M | $-22.14M | 70.15% | -16.61% | -20.96% |
| 2022 | $99.50M | $-43.70M | 66.30% | -35.05% | -43.92% |
| 2023 | $76.35M | $-37.25M | 68.32% | -37.08% | -48.79% |
| 2024 | $64.83M | $-47.00M | 68.34% | -41.93% | -72.49% |